U-Neuron Biomedical

U-Neuron Biomedical Intangible Assets

The Intangible Assets of U-Neuron Biomedical (6973.TWO) as of Oct 27, 2026 is 946,000.00 TWD. In the previous year, Intangible Assets was 1.25 M TWD — a change of -24.50% (lower).

Intangible Assets

946,000.00TWD

YoY

-24.50%

Last updated:

Intangible Assets of U-Neuron Biomedical is 2024 946,000.00 TWD. Intangible Assets of U-Neuron Biomedical was 2023 1.25 M TWD. It decreases by -24.50% lower compared to the previous year.

The U-Neuron Biomedical Intangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Intangible Assets
Date
Intangible Assets
Jan 1, 2021
4.04 M TWD
Jan 1, 2022
2.08 M TWD
Jan 1, 2023
1.25 M TWD
Jan 1, 2024
946,000.00 TWD
The U-Neuron Biomedical Intangible Assets history
YEARIntangible AssetsYoY
946,000.00TWD-24.50%
1.25 MTWD-39.64%
2.08 MTWD-48.66%
4.04 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

U-Neuron Biomedical Stock analysis

What does U-Neuron Biomedical do? U-Neuron Biomedical Inc develops cosmetics, health care consumer products, and new drugs using allogeneic amniotic fluid stem cells and their derivatives. The company's new drug portfolio includes UA002 for erectile dysfunction and UB003 for dry eye, while its cosmetic line features masks, essences, and creams for anti-aging, repairing, and moisturizing. These products are primarily sold within Taiwan, targeting domestic consumers seeking medical beauty and health care solutions. The company leverages the regenerative properties of amniotic fluid stem cells to create applications in both therapeutic and cosmetic segments. The business model focuses on developing products around deer amniotic fluid stem cell derivatives for cosmetics, which form the core of its health care consumer product line. UA002 and UB003 represent the company's pharmaceutical offerings, addressing specific medical conditions with stem cell-based treatments. Domestic sales drive revenue, with no mention of international markets or additional distribution channels in the provided description. U-Neuron Biomedical Inc's revenue streams come from the domestic sale of its cosmetic products and pharmaceuticals. The company's product segments are clearly divided between new drug development and cosmetic/health care consumer products, with each segment utilizing stem cell technology in different applications. Sales are concentrated within Taiwan, where the company's products meet local demand for regenerative medicine and beauty solutions. U-Neuron Biomedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about U-Neuron Biomedical stock

Intangible Assets of U-Neuron Biomedical is 946,000.00 TWD in 2024.

Intangible Assets of U-Neuron Biomedical changed from 1.25 M TWD to 946,000.00 TWD, representing a -24.50% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Intangible Assets U-Neuron Biomedical since 2006 – with annual values, charts, and detailed analysis.

Intangible assets are non-physical assets such as patents, trademarks, copyrights, and software. They can be significant value drivers for technology and pharmaceutical companies.

Intangible Assets's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Intangible Assets's U-Neuron Biomedical historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — U-Neuron Biomedical

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — U-Neuron Biomedical